0002160318-26-000001.txt : 20261112
0002160318-26-000001.hdr.sgml : 20261112
20261112145441
ACCESSION NUMBER: 0002160318-26-000001
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering
ITEM INFORMATION: Investment Company Act Section 3(c)
ITEM INFORMATION: Section 3(c)(7)
FILED AS OF DATE: 20261112
DATE AS OF CHANGE: 20261112
EFFECTIVENESS DATE: 20261112
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Avalon BioVentures II, LP
CENTRAL INDEX KEY: 0002160318
ORGANIZATION NAME:
EIN: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-604534
FILM NUMBER: 261546147
BUSINESS ADDRESS:
STREET 1: 11099 NORTH TORREY PINES ROAD, SUITE 290
CITY: LA JOLLA
STATE: CA
ZIP: 92037
BUSINESS PHONE: 858-401-3343
MAIL ADDRESS:
STREET 1: 11099 NORTH TORREY PINES ROAD, SUITE 290
CITY: LA JOLLA
STATE: CA
ZIP: 92037
D
1
primary_doc.xml
X0708
D
LIVE
0002160318
Avalon BioVentures II, LP
11099 NORTH TORREY PINES ROAD, SUITE 290
LA JOLLA
CA
CALIFORNIA
92037
858-401-3343
DELAWARE
None
None
Limited Partnership
true
2026
N/A
Avalon BioVentures II GP, LLC
11099 North Torrey Pines Road, Suite 290
La Jolla
CA
CALIFORNIA
92037
Director
General Partner of the Issuer
Tighe
Reardon
11099 North Torrey Pines Road, Suite 290
La Jolla
CA
CALIFORNIA
92037
Director
Managing Director of the General Partner of the Issuer
Jay
Lichter
11099 North Torrey Pines Road, Suite 290
La Jolla
CA
CALIFORNIA
92037
Director
Managing Director of the General Partner of the Issuer
Sanford
Madigan
11099 North Torrey Pines Road, Suite 290
La Jolla
CA
CALIFORNIA
92037
Director
Managing Director of the General Partner of the Issuer
Sergio
Duron
11099 North Torrey Pines Road, Suite 290
La Jolla
CA
CALIFORNIA
92037
Director
Managing Director of the General Partner of the Issuer
Pooled Investment Fund
Venture Capital Fund
false
Decline to Disclose
- 06b
- 3C
- 3C.7
false
true
false
true
false
0
200000000
0
200000000
false
0
0
0
0
The Issuer's General Partner (or its designee) is entitled to a management fee payable by the Issuer.
false
Avalon BioVentures II, LP
/s/ Tighe Reardon
Tighe Reardon
Managing Director of the General Partner of the Issuer
2026-11-12